It develops gradually and may worsen if left untreated. Rosacea can affect people of all skin tones, but it’s most frequently reported in individuals with fair skin. It commonly arises after age 30.
Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...
The drug was cleared to treat inflammatory lesions of rosacea in adults after proving its superiority over Galderma’s standard-of-care Oracea capsules, as well as placebo, in two 16-week phase 3 ...